1-7 of 7
C. Gambacorti Passerini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bosutinib (SKI-606) Demonstrates Clinical Activity and Is Well Tolerated among Patients with AP and BP CML and Ph+ ALL.

C. Gambacorti-Passerini, MD, H. Kantarjian, MD, T. Bruemmendorf, MD, G. Martinelli, MD, M. Baccarani, MD, T. Fischer, MD, E.M. Pogliani, MD, B. Hewes, MD, A.D.G. Volkert, MD, N. Bardy-Bouxin, MD, J. Cortes, MD
Journal: Blood
Blood (2007) 110 (11): 473.
https://doi.org/10.1182/blood.V110.11.473.473
Published: 2007
Journal Articles

Efficacy and Safety of Bosutinib (SKI-606) among Patients with Chronic Phase Ph+ Chronic Myelogenous Leukemia (CML).

J. Cortes, MD, T. Bruemmendorf, MD, H. Kantarjian, MD, J. Khoury, MD, G. Rosti, MD, T. Fischer, MD, L. Tornaghi, MD, B. Hewes, MD, E.C. Martin, MD, C. Gambacorti-Passerini, MD
Journal: Blood
Blood (2007) 110 (11): 733.
https://doi.org/10.1182/blood.V110.11.733.733
Published: 2007
Journal Articles

Cancer Procoagulant and Tissue Factor Are Differently Modulated by All- trans -Retinoic Acid in Acute Promyelocytic Leukemia Cells

A. Falanga, R. Consonni, M. Marchetti, G. Locatelli, E. Garattini, C. Gambacorti Passerini, S.G. Gordon, T. Barbui
Journal: Blood
Blood (1998) 92 (1): 143–151.
https://doi.org/10.1182/blood.V92.1.143.413k18_143_151
Published: 1998
Journal Articles

In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide nucleic acid

C Gambacorti-Passerini, L Mologni, C Bertazzoli, P le Coutre, E Marchesi, F Grignani, PE Nielsen
Journal: Blood
Blood (1996) 88 (4): 1411–1417.
https://doi.org/10.1182/blood.V88.4.1411.bloodjournal8841411
Published: 1996
Journal Articles

Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase

L Benedetti, F Grignani, BM Scicchitano, AM Jetten, D Diverio, F Lo Coco, G Avvisati, C Gambacorti-Passerini, S Adamo, AA Levin, PG Pelicci, C Nervi
Journal: Blood
Blood (1996) 87 (5): 1939–1950.
https://doi.org/10.1182/blood.V87.5.1939.1939
Published: 1996
Journal Articles

Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein

S Dermime, F Grignani, M Clerici, C Nervi, G Sozzi, GP Talamo, E Marchesi, F Formelli, G Parmiani, PG Pelicci, C Gambacorti-Passerini
Journal: Blood
Blood (1993) 82 (5): 1573–1577.
https://doi.org/10.1182/blood.V82.5.1573.1573
Published: 1993
Journal Articles

Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells

C Gambacorti-Passerini, F Grignani, F Arienti, PP Pandolfi, PG Pelicci, G Parmiani
Journal: Blood
Blood (1993) 81 (5): 1369–1375.
https://doi.org/10.1182/blood.V81.5.1369.1369
Published: 1993